Polaris Market Research today announced findings from its latest report, projecting the global transplant monitoring kits market to grow from USD 5,064.56 million in 2022 to USD 7,723.22 million by 2032, at a CAGR of 4.3% from 2023 to 2032. The report profiles 13 leading companies across six market segments, covering market size, market share, and industry trends.

Analyst Commentary on Transplant Monitoring Kits Market Growth

“Rising transplant volumes and steady advances in assays and reagents are driving market growth, while molecular testing and remote monitoring are shaping industry trends,” said a Polaris Market Research analyst. “The opportunity lies with providers that can deliver accurate, non-invasive monitoring tools to transplant centers and reference laboratories.”

Key Growth Drivers, Major Companies and Segments Covered

Growth Drivers: The escalating rate of transplantation is the primary force behind the market’s expansion, as every additional procedure raises demand for tools that track graft health and immune response. Partnerships, product launches, and acquisitions are adding further momentum. In October 2020, Thermo Fisher Scientific signed a partnership with the Terasaki Innovation Centre to advance diagnostic and treatment options for transplant patients, and in April 2022 Fujirebio Holdings launched the Lumipulse Presto iTACT Tacrolimus reagent for monitoring immunosuppressive therapy.

Market Challenges: The high cost of monitoring kits remains a restraint on wider adoption. COVID-19 also postponed non-urgent transplant procedures and reduced demand during the pandemic. At the same time, it accelerated telemedicine and remote monitoring, opening new opportunities for home-based biomarker tracking and connected monitoring technologies.

Major Companies Covered: CareDx, Biogenuix Medsystems, Thermo Fisher Scientific, Eurofins Scientific, JETA Molecular, ELITech, QIAGEN, Hologic, Natera, Roche, Bio-Rad Laboratories, Genome Diagnostics, and Sanbio.

Segments Covered: By Product Type (Reagents & Consumables, Instruments, Software & Services), By Technology (Molecular Assay, Non-molecular Assay), By Transplant (Solid Organ, Stem Cell, Soft Tissue), By Application (Diagnostic, Research), By End User (Independent Reference Laboratories, Hospitals & Transplant Centres, Research Laboratories & Academic Institutes), and By Region.

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐓𝐡𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐞𝐫𝐞 :

https://www.polarismarketresearch.com/industry-analysis/transplant-monitoring-kits-market 

Segment Insights: Molecular Assays and Reagents Lead

Molecular assay technology held the largest share in 2022, offering high sensitivity and specificity and often relying on non-invasive blood or urine samples. Reagents and consumables led by product type because they must be replenished for every test. The soft tissue segment is expected to grow at the fastest CAGR, supported by rising burn injuries, trauma cases, and age-related degenerative conditions. Diagnostic applications accounted for the largest share through rejection surveillance and immunosuppressive drug monitoring, and independent reference laboratories are expected to dominate by end user, offering immunological assays, HLA typing, drug monitoring, and biomarker analysis under one roof.

Recent Developments in the Transplant Monitoring Kits Market

• January 2024: CareDx introduced AlloSure Lung, a non-invasive blood test that measures donor-derived cell-free DNA to help monitor lung transplant patients for early signs of rejection.
• March 2023: LiveOnNY and MediGO announced a collaboration using real-time GPS monitoring to track organs as they travel nationwide.
• April 2022: Fujirebio Holdings launched the Lumipulse Presto iTACT Tacrolimus in-vitro diagnostic reagent for the Lumipulse L2400 system.

Regional Snapshot: North America Leads, Europe Shows Significant Growth

North America led the market in 2022, supported by innovation in monitoring kits, strong awareness of organ transplantation, and regional R&D, including a collaboration between MIT and the American Organ Transplant System on an AI-driven framework to improve equity in organ allocation. Europe is expected to show significant growth on the back of advanced healthcare infrastructure. Germany’s medical device market alone generates about USD 35.8 billion yearly, roughly 25.6% of the European total.

Why It Matters for Buyers Evaluating Transplant Monitoring Kits Market Forecast

For stakeholders researching the transplant monitoring kits market forecast, the underlying report benchmarks market share, company positioning, and segment-level forecasts to support sourcing, partnership, and investment decisions through 2032. It also includes Porter’s Five Forces and PESTLE analysis, and can be customized by region, country, or additional segment.

More Trending Latest Reports By Polaris Market Research:

Naphtha Market

Europe Laboratory Developed Tests Market

Medical Batteries Market

Clindamycin Phosphate Injection Market

Europe Laboratory Developed Tests Market

Digital Transaction Management Market

Metallic Stearates Market

Treating Anemia with Erythropoietin Drugs Market

Fuel Cell Market